RecruitingNCT07433660

WellSpan-THRIVE Cancer QOL Study

WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]


Sponsor

WellSpan Health

Enrollment

1,000 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences. This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study measures quality of life in people newly diagnosed with cancer to understand how their wellbeing changes over time and what factors affect it most. WellSpan Health's THRIVE programme supports participants during this process. **You may be eligible if...** - You are 18 or older - You have received a primary cancer diagnosis within the past 6 months - You are able to sign an informed consent form **You may NOT be eligible if...** - You are under 18 - Your cancer is non-melanoma skin cancer, a brain tumour or brain metastasis, or a blood cancer (such as leukaemia or lymphoma) - You have severe cognitive impairment that prevents you from consenting Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

WellSpan Medical Oncology & Hematology

Chambersburg, Pennsylvania, United States

WellSpan Ephrata Cancer Center

Ephrata, Pennsylvania, United States

WellSpan Adams Cancer Center

Gettysburg, Pennsylvania, United States

WellSpan Sechler Family Cancer Center

Lebanon, Pennsylvania, United States

WellSpan York Cancer Center

York, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07433660


Related Trials